Scarless SARS-CoV-2 Genome Engineering and Variant Analysis
This study introduces a safe, scarless BAC-based reverse genetics system for SARS-CoV-2 that enables precise engineering of viral variants to quantitatively assess antiviral drug efficacy, resistance mechanisms, and the impact of drug efflux transporters without requiring wildtype isolates.